NO20092019L - Behandling av gjennomtrengende utviklingsforstyrrelser - Google Patents
Behandling av gjennomtrengende utviklingsforstyrrelserInfo
- Publication number
- NO20092019L NO20092019L NO20092019A NO20092019A NO20092019L NO 20092019 L NO20092019 L NO 20092019L NO 20092019 A NO20092019 A NO 20092019A NO 20092019 A NO20092019 A NO 20092019A NO 20092019 L NO20092019 L NO 20092019L
- Authority
- NO
- Norway
- Prior art keywords
- disorder
- developmental disorders
- pervasive developmental
- treatment
- pdds
- Prior art date
Links
- 208000029560 autism spectrum disease Diseases 0.000 title abstract 7
- 208000012202 Pervasive developmental disease Diseases 0.000 title abstract 5
- 208000036640 Asperger disease Diseases 0.000 abstract 2
- 201000006062 Asperger syndrome Diseases 0.000 abstract 2
- 208000020706 Autistic disease Diseases 0.000 abstract 2
- 208000006289 Rett Syndrome Diseases 0.000 abstract 2
- 208000036353 Rett disease Diseases 0.000 abstract 2
- 201000007197 atypical autism Diseases 0.000 abstract 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 2
- 238000000034 method Methods 0.000 abstract 2
- 150000004657 carbamic acid derivatives Chemical class 0.000 abstract 1
- 238000002648 combination therapy Methods 0.000 abstract 1
- 229940079593 drug Drugs 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 238000009097 single-agent therapy Methods 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Psychiatry (AREA)
- Epidemiology (AREA)
- Hospice & Palliative Care (AREA)
- Pain & Pain Management (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US86359506P | 2006-10-31 | 2006-10-31 | |
| PCT/US2007/081365 WO2008054984A1 (fr) | 2006-10-31 | 2007-10-15 | Traitement des troubles pervasifs du développement |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NO20092019L true NO20092019L (no) | 2009-06-23 |
Family
ID=39145417
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20092019A NO20092019L (no) | 2006-10-31 | 2009-05-25 | Behandling av gjennomtrengende utviklingsforstyrrelser |
Country Status (17)
| Country | Link |
|---|---|
| US (1) | US20080103199A1 (fr) |
| EP (1) | EP2089011A1 (fr) |
| JP (1) | JP2010508354A (fr) |
| KR (1) | KR20090080105A (fr) |
| CN (1) | CN101568333A (fr) |
| AU (1) | AU2007313911A1 (fr) |
| BR (1) | BRPI0718323A2 (fr) |
| CA (1) | CA2667909A1 (fr) |
| CO (1) | CO6180427A2 (fr) |
| EA (1) | EA200970435A1 (fr) |
| GT (1) | GT200900112A (fr) |
| IL (1) | IL198488A0 (fr) |
| MX (1) | MX2009004798A (fr) |
| NI (1) | NI200900074A (fr) |
| NO (1) | NO20092019L (fr) |
| WO (1) | WO2008054984A1 (fr) |
| ZA (1) | ZA200903772B (fr) |
Families Citing this family (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7702468B2 (en) | 2006-05-03 | 2010-04-20 | Population Diagnostics, Inc. | Evaluating genetic disorders |
| US10522240B2 (en) | 2006-05-03 | 2019-12-31 | Population Bio, Inc. | Evaluating genetic disorders |
| WO2010020585A1 (fr) * | 2008-08-18 | 2010-02-25 | INSERM (Institut National de la Santé et de la Recherche Médicale) | Inhibiteurs de la recapture de la sérotonine destinés au traitement du syndrome de rett |
| EP2601609B1 (fr) | 2010-08-02 | 2017-05-17 | Population Bio, Inc. | Compositions et méthodes de recherche de mutations causales dans des troubles génétiques |
| US8609849B1 (en) | 2010-11-30 | 2013-12-17 | Fox Chase Chemical Diversity Center, Inc. | Hydroxylated sulfamides exhibiting neuroprotective action and their method of use |
| EP2766483B1 (fr) | 2011-10-10 | 2022-03-23 | The Hospital For Sick Children | Méthodes et compositions de dépistage et de traitement de troubles du développement |
| EP2773779B1 (fr) | 2011-11-04 | 2020-10-14 | Population Bio, Inc. | Méthodes et compositions pour le diagnostic, le pronostic et le traitement d'états neurologiques |
| WO2013120018A1 (fr) * | 2012-02-09 | 2013-08-15 | Population Diagnostics, Inc. | Méthodes et compositions permettant de rechercher et de traiter des troubles du développement |
| JP2015524474A (ja) * | 2012-08-06 | 2015-08-24 | エスワン バイオファーマ インコーポレイテッド | 治療レジメン |
| DK2895621T3 (da) | 2012-09-14 | 2020-11-30 | Population Bio Inc | Fremgangsmåder og sammensætning til diagnosticering, prognose og behandling af neurologiske tilstande |
| EP2900835B1 (fr) | 2012-09-27 | 2025-04-30 | Population Bio, Inc. | Procédé de dépistage et de traitement de troubles du développement |
| CN105164103B (zh) * | 2013-03-12 | 2019-12-06 | 比皮艾思药物研发有限公司 | 苯基氨基甲酸酯化合物和含有其的预防或治疗记忆缺失相关疾病的组合物 |
| US10724096B2 (en) | 2014-09-05 | 2020-07-28 | Population Bio, Inc. | Methods and compositions for inhibiting and treating neurological conditions |
| KR102635938B1 (ko) | 2016-12-14 | 2024-02-13 | 에스케이바이오팜 주식회사 | 양극성 장애의 예방, 경감 또는 치료를 위한 카바메이트 화합물의 용도 |
| US10240205B2 (en) | 2017-02-03 | 2019-03-26 | Population Bio, Inc. | Methods for assessing risk of developing a viral disease using a genetic test |
| GB2571696B (en) | 2017-10-09 | 2020-05-27 | Compass Pathways Ltd | Large scale method for the preparation of Psilocybin and formulations of Psilocybin so produced |
| US12459965B2 (en) | 2017-10-09 | 2025-11-04 | Compass Pathfinder Limited | Preparation of psilocybin, different polymorphic forms, intermediates, formulations and their use |
| CA3108807A1 (fr) | 2018-08-08 | 2020-02-13 | Pml Screening, Llc | Procedes pour evaluer le risque de developper une leucoencephalopathie multifocale progressive provoquee par le virus de john cunningham par des procedes de test genetique pour ev aluer le risque de developper une leucoencephalopathie multifocale progressive provoquee par le virus de john cunningham par test genetique |
| CN113993523A (zh) | 2019-04-17 | 2022-01-28 | 指南针探路者有限公司 | 用赛洛西宾治疗抑郁症和其他各种病症 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR100886578B1 (ko) * | 2001-02-27 | 2009-03-05 | 오르토-맥네일 파마슈티칼, 인코퍼레이티드 | 카바메이트 화합물을 포함하는 정신증 장애 예방용 또는 치료용 약제학적 조성물 |
| ATE369130T1 (de) * | 2001-02-27 | 2007-08-15 | Ortho Mcneil Pharm Inc | Carbamatverbindungen zur vorbeugung und behandlung von bewegungsstörungen |
| PT1383489E (pt) * | 2001-02-27 | 2007-06-21 | Ortho Mcneil Pharm Inc | Compostos carbamato para utilização na prevenção ou tratamento de distúrbios neurodegenerativos |
| CN1250215C (zh) * | 2001-02-27 | 2006-04-12 | 奥索-麦克尼尔药品公司 | 用于预防或治疗双相性精神障碍的氨基甲酸酯化合物 |
| CN101056629B (zh) * | 2004-09-16 | 2012-01-11 | 詹森药业有限公司 | 2-苯基-1,2-乙二醇-(二)氨基甲酸酯在制备治疗癫痫发生的药物中的用途 |
-
2007
- 2007-10-15 MX MX2009004798A patent/MX2009004798A/es not_active Application Discontinuation
- 2007-10-15 KR KR1020097011061A patent/KR20090080105A/ko not_active Withdrawn
- 2007-10-15 CA CA002667909A patent/CA2667909A1/fr not_active Abandoned
- 2007-10-15 BR BRPI0718323-2A patent/BRPI0718323A2/pt not_active Application Discontinuation
- 2007-10-15 JP JP2009535384A patent/JP2010508354A/ja not_active Withdrawn
- 2007-10-15 EA EA200970435A patent/EA200970435A1/ru unknown
- 2007-10-15 EP EP07844287A patent/EP2089011A1/fr not_active Withdrawn
- 2007-10-15 US US11/872,177 patent/US20080103199A1/en not_active Abandoned
- 2007-10-15 CN CNA2007800482055A patent/CN101568333A/zh active Pending
- 2007-10-15 AU AU2007313911A patent/AU2007313911A1/en not_active Abandoned
- 2007-10-15 WO PCT/US2007/081365 patent/WO2008054984A1/fr not_active Ceased
-
2009
- 2009-04-30 NI NI200900074A patent/NI200900074A/es unknown
- 2009-04-30 IL IL198488A patent/IL198488A0/en unknown
- 2009-04-30 GT GT200900112A patent/GT200900112A/es unknown
- 2009-05-25 NO NO20092019A patent/NO20092019L/no not_active Application Discontinuation
- 2009-05-29 ZA ZA200903772A patent/ZA200903772B/xx unknown
- 2009-06-01 CO CO09056106A patent/CO6180427A2/es not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| MX2009004798A (es) | 2009-08-12 |
| EP2089011A1 (fr) | 2009-08-19 |
| CO6180427A2 (es) | 2010-07-19 |
| ZA200903772B (en) | 2010-08-25 |
| KR20090080105A (ko) | 2009-07-23 |
| CA2667909A1 (fr) | 2008-05-08 |
| JP2010508354A (ja) | 2010-03-18 |
| CN101568333A (zh) | 2009-10-28 |
| EA200970435A1 (ru) | 2009-10-30 |
| AU2007313911A1 (en) | 2008-05-08 |
| GT200900112A (es) | 2010-05-18 |
| NI200900074A (es) | 2010-02-01 |
| WO2008054984A1 (fr) | 2008-05-08 |
| BRPI0718323A2 (pt) | 2013-11-26 |
| US20080103199A1 (en) | 2008-05-01 |
| IL198488A0 (en) | 2010-02-17 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO20092019L (no) | Behandling av gjennomtrengende utviklingsforstyrrelser | |
| EA200901032A1 (ru) | Соединения и композиции в качестве модуляторов активности gpr119 | |
| EA201100138A1 (ru) | 4-феноксиметилпиперидины в качестве модуляторов активности gpr119 | |
| EA201391786A1 (ru) | Галоген-алкил-1,3-оксазины в качестве ингибиторов bace1 и/или bace2 | |
| EA201391670A1 (ru) | 1,3-оксазины в качестве ингибиторов bace1 и/или bace2 | |
| BR112013031510A2 (pt) | [1,3]oxazinas | |
| TW200638934A (en) | Heteroaryl compounds as P2Y1 receptor inhibitors | |
| CL2012003401A1 (es) | Compuestos derivados de carbamato de hexafluoroisopropilo, inhibidores de la enzima monoacil glicerol lipasa (mgl); proceso de preparacion; medicamento; compuestos intermediarios; composicion farmaceutica; y su uso para tratar o prevenir dolores agudos o cronicos, vertigos, dislipidemias y epilepsia, entre otras enfermedades. | |
| EA201391752A1 (ru) | Спиро-[1,3]-оксазины и спиро-[1,4]-оксазепины в качестве ингибиторов bace1 и/или bace2 | |
| EA201200570A1 (ru) | Соединения и композиции в качестве модуляторов активности gpr119 | |
| EA201200054A1 (ru) | Лечение токотриенолами или экстрактами, богатыми токотриенолами, первазивных расстройств развития | |
| EA201001329A1 (ru) | Соединения и композиции в качестве модуляторов активности gpr119 | |
| DOP2006000170A (es) | Nuevos derivados de espirocromanona | |
| EA201692506A3 (ru) | Ингибиторы репликации вирусов гриппа | |
| EA200800564A1 (ru) | Производные ксантина как селективные агонисты нм74а | |
| EA201071045A1 (ru) | Соединения оксадиазоантрацена для лечения диабета | |
| EA200901166A1 (ru) | Соединения и композиции в качестве модуляторов активности gpr 119 | |
| ECSP067043A (es) | Derivados de pirrolotriazina útiles para tratar trastornos hiper-proliferativos y enfermedades asociadas con angiogénesis | |
| EA201001332A1 (ru) | Соединения и композиции в качестве модуляторов активности gpr119 | |
| EA201270144A1 (ru) | Комбинированная терапия при лечении диабета | |
| EA201001330A1 (ru) | Соединения и композиции в качестве модуляторов активности gpr119 | |
| NO20083036L (no) | Anvendelse av benzofuserte heterocykliske sulfamidderivater for behandling av depresjon | |
| EA201290517A1 (ru) | Гетероароматические арилтриазольные производные в качестве ингибиторов фермента pde10a | |
| NO20076425L (no) | Fremgangsmater for behandling av drug-resistent cancer | |
| NO20071314L (no) | Peptidiske vasopressinreseptoragonister |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |